CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Survey GroupWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug647 Convalescent Plasma Wiki 0.22

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D007239 Infection NIH 0.06
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY

Background COVID-19 has brought into questioning the equitable distribution of resources. Solid Organ Transplants (SOT) are life-saving procedures. Rapid changes in the management of patients are occurring, with potential for inequity. Drawing on professionals across transplant specialities, we investigated resource distribution specifically for SOT to guide healthcare policies. A multidisciplinary team developed a survey. The survey included demographic questions to contextualise respondents, questions on resource allocation for SOT. Multiple strategies were used to distribute the survey internationally. Descriptive, uni-multivariate ordinal regressions analysis were performed. Open comments were analysed using qualitative methods.

NCT04367896 COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION Other: Survey Group

Primary Outcomes

Description: Question 1"Given the COVID-19 outbreak, should liver transplant activities be stopped?" with three possible answers (Completely, Selectively and Not at All)

Measure: Management of Solid Organ Transplant during COVID-19 pandemic

Time: 20/04/2020

Description: Question 2"I feel that the current policy to allocate most resources to COVID-19 meets the equity of access in healthcare for different diseases" with four possible alternative answers (strongly agree, partially agree, partially disagree and strongly disagree).

Measure: Equity of resource distribution

Time: 20/04/2020

Secondary Outcomes

Description: Scale (10 strongly agree- 0 strongly disagree).

Measure: Equity rank of resource distribution

Time: 20/04/2020


No related HPO nodes (Using clinical trials)